C&C International Co., Ltd.

KOSDAQ:A352480 Stock Report

Market Cap: ₩420.9b

C&C International Valuation

Is A352480 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A352480 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: A352480 (₩42100) is trading below our estimate of fair value (₩154995.91)

Significantly Below Fair Value: A352480 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for A352480?

Key metric: As A352480 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for A352480. This is calculated by dividing A352480's market cap by their current earnings.
What is A352480's PE Ratio?
PE Ratio11.1x
Earnings₩38.04b
Market Cap₩420.88b

Price to Earnings Ratio vs Peers

How does A352480's PE Ratio compare to its peers?

The above table shows the PE ratio for A352480 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average16.2x
A237880 CLIO CosmeticsLtd
8.6x11.8%₩311.1b
A439090 Manyo Factory
16.6x54.6%₩268.3b
A200130 KOLMAR BNHLtd
24xn/a₩380.8b
A241710 Cosmecca Korea
15.5x23.4%₩554.3b
A352480 C&C International
11.1x29.8%₩420.9b

Price-To-Earnings vs Peers: A352480 is good value based on its Price-To-Earnings Ratio (11.1x) compared to the peer average (16.2x).

Price to Earnings Ratio vs Industry

How does A352480's PE Ratio compare vs other companies in the KR Personal Products Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
A900120 CXI Healthcare Technology Group
0.7xn/aUS$15.71m
No more companies available in this PE range
A352480 11.1xIndustry Avg. 16.3xNo. of Companies7PE01020304050+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: A352480 is good value based on its Price-To-Earnings Ratio (11.1x) compared to the KR Personal Products industry average (16.2x).

Price to Earnings Ratio vs Fair Ratio

What is A352480's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A352480 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio11.1x
Fair PE Ratio17.5x

Price-To-Earnings vs Fair Ratio: A352480 is good value based on its Price-To-Earnings Ratio (11.1x) compared to the estimated Fair Price-To-Earnings Ratio (17.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst A352480 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₩39,900.00
₩115,333.33
+189.1%
29.0%₩160,000.00₩70,000.00n/a6
Nov ’25₩63,500.00
₩124,333.33
+95.8%
19.9%₩160,000.00₩95,000.00n/a6
Oct ’25₩94,000.00
₩126,400.00
+34.5%
21.1%₩160,000.00₩95,000.00n/a5
Sep ’25₩102,900.00
₩118,000.00
+14.7%
19.6%₩150,000.00₩95,000.00n/a4
Aug ’25₩122,000.00
₩118,000.00
-3.3%
19.6%₩150,000.00₩95,000.00n/a4
Jul ’25₩122,700.00
₩105,500.00
-14.0%
13.5%₩130,000.00₩95,000.00n/a4
Jun ’25₩91,400.00
₩105,500.00
+15.4%
13.5%₩130,000.00₩95,000.00n/a4
May ’25₩84,700.00
₩88,750.00
+4.8%
7.5%₩97,000.00₩80,000.00n/a4
Apr ’25₩80,100.00
₩86,500.00
+8.0%
5.5%₩93,000.00₩80,000.00n/a4
Mar ’25₩66,900.00
₩86,500.00
+29.3%
5.5%₩93,000.00₩80,000.00n/a4
Feb ’25₩65,000.00
₩81,000.00
+24.6%
1.7%₩83,000.00₩80,000.00n/a3
Jan ’25₩62,400.00
₩72,500.00
+16.2%
7.1%₩80,000.00₩66,000.00n/a4
Dec ’24₩61,000.00
₩70,000.00
+14.8%
4.7%₩74,000.00₩66,000.00n/a3
Nov ’24₩58,800.00
₩70,666.67
+20.2%
4.8%₩74,000.00₩66,000.00₩63,500.003

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

NeoPharm

₩187.3b

Engages in the manufacturing and sale of skin care products in South Korea.

A092730

₩12,280.00

7D

3.7%

1Y

7.5%

NOVAREXLtd

₩134.4b

Manufactures, wholesales, and retails health and functional foods in South Korea and internationally.

A194700

₩7,590.00

7D

0.7%

1Y

-30.9%

Bonne

₩58.7b

Develops and supplies cosmetics in South Korea.

A226340

₩1,400.00

7D

5.5%

1Y

-47.0%